Skip to content

Hepatitis C in HIV-positive gay men: Amsterdam, Paris, New York and UK compared

Tenofovir provides good hepatitis B virus suppression in HIV/HBV co-infected patients

Half of HIV/HCV co-infected early responders are cured with 72-week treatment

Hospitalisation and disability are higher amongst HIV patients with hepatitis C coinfection

Hepatitis C: high rate of treatment success in recently infected HIV positive gay men

Study supports early initiation of HIV treatment by HIV/hepatitis C co-infected patients

Weak immune system may explain increased risk of death seen in HIV/hepatitis C co-infected patients

Atazanavir-treated patients have increased risk of hyperbilirubinaemia after starting therapy for hepatitis C

HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent